• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新型冠状病毒肺炎患者的早期检测与病情评估]

[Early detection and disease assessment of patients with novel coronavirus pneumonia].

作者信息

Zhou L, Liu H G

机构信息

Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030.

出版信息

Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 5;43(0):E003. doi: 10.3760/cma.j.issn.1001-0939.2020.0003.

DOI:10.3760/cma.j.issn.1001-0939.2020.0003
PMID:32023686
Abstract

In December 2019, the outbreak of novel coronavirus (2019- nCoV) in wuhan, China, attracting attention worldwidely. The novel coronavirus has the characteristics of rapid transmission, atypical clinical symptoms, and easy to affect both lungs, leading to missed diagnosis and misdiagnosis, as well as difficult to detection and assessment at early stage. Fever, cough, myalgia, weakness, dyspnea and imagings may be helpful for the early detection of novel coronavirus pneumonia. At the same time, the rate of disease progression, fever, CT manifestations, hypoxia degree, age, basic diseases, and laboratory indicators can also be used to evaluate the severity of the novel coronavirus pneumonia.

摘要

2019年12月,中国武汉爆发新型冠状病毒(2019 - nCoV),引起了全球关注。新型冠状病毒具有传播迅速、临床症状不典型、易累及双肺等特点,导致漏诊、误诊,且早期难以检测和评估。发热、咳嗽、肌痛、乏力、呼吸困难及影像学表现可能有助于新型冠状病毒肺炎的早期发现。同时,疾病进展速度、发热情况、CT表现、缺氧程度、年龄、基础疾病及实验室指标等也可用于评估新型冠状病毒肺炎的严重程度。

相似文献

1
[Early detection and disease assessment of patients with novel coronavirus pneumonia].[新型冠状病毒肺炎患者的早期检测与病情评估]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 5;43(0):E003. doi: 10.3760/cma.j.issn.1001-0939.2020.0003.
2
[Early detection and disease assessment of patients with novel coronavirus pneumonia].[新型冠状病毒肺炎患者的早期检测与病情评估]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):167-170. doi: 10.3760/cma.j.issn.1001-0939.2020.03.003.
3
Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.2019新型冠状病毒感染患者队列中与疾病进展相关的危险因素。
Ann Palliat Med. 2020 Mar;9(2):428-436. doi: 10.21037/apm.2020.03.26. Epub 2020 Mar 17.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China.中国浙江省 2019 年新型冠状病毒肺炎的临床特征。
Mol Med Rep. 2020 Sep;22(3):2583-2587. doi: 10.3892/mmr.2020.11329. Epub 2020 Jul 10.
6
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV:流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
7
[Comparison of the clinical characteristics between RNA positive and negative patients clinically diagnosed with coronavirus disease 2019].[临床诊断为2019冠状病毒病的RNA阳性与阴性患者临床特征比较]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 May 12;43(5):427-430. doi: 10.3760/cma.j.cn112147-20200214-00095.
8
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia.新型冠状病毒(2019-nCoV)肺炎的诊治进展。
Radiology. 2020 Apr;295(1):210-217. doi: 10.1148/radiol.2020200274. Epub 2020 Feb 6.
9
[Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China].中国北方六省(自治区)31例儿童2019新型冠状病毒感染的临床分析
Zhonghua Er Ke Za Zhi. 2020 Apr 2;58(4):269-274. doi: 10.3760/cma.j.cn112140-20200225-00138.
10
CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China.重症新型冠状病毒肺炎(COVID-19)的CT表现:中国黑龙江省1例病例报告
Open Med (Wars). 2020 Jun 13;15(1):563-566. doi: 10.1515/med-2020-0151. eCollection 2020.

引用本文的文献

1
Effect of SARS-CoV-2 on semen parameters: A meta-analysis of 39 articles from 15 countries.SARS-CoV-2 对精液参数的影响:来自 15 个国家的 39 篇文章的荟萃分析。
J Glob Health. 2024 Aug 30;14:05021. doi: 10.7189/jogh.14.05021.
2
Analysis of COVID-19 severity from the perspective of coagulation index using evolutionary machine learning with enhanced brain storm optimization.基于增强型头脑风暴优化的进化机器学习从凝血指标角度分析新型冠状病毒肺炎严重程度
J King Saud Univ Comput Inf Sci. 2022 Sep;34(8):4874-4887. doi: 10.1016/j.jksuci.2021.09.019. Epub 2021 Oct 1.
3
Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets.
木犀草素通过生物信息学方法治疗前列腺癌和 COVID-19 的分析:临床发现和药物靶点。
Front Endocrinol (Lausanne). 2022 Feb 1;12:802447. doi: 10.3389/fendo.2021.802447. eCollection 2021.
4
Clinical characteristics of patients with confirmed and suspected COVID-19.确诊和疑似新冠肺炎患者的临床特征
Am J Transl Res. 2021 Nov 15;13(11):12897-12904. eCollection 2021.
5
Microbiota, probiotics and respiratory infections: the three musketeers can tip off potential management of COVID-19.微生物群、益生菌与呼吸道感染:这三位“火枪手”可为新冠病毒潜在治疗提供线索。
Am J Transl Res. 2021 Oct 15;13(10):10977-10993. eCollection 2021.
6
Exploration of antigenic determinants in spike glycoprotein of SARS-CoV2 and identification of five salient potential epitopes.新型冠状病毒刺突糖蛋白抗原决定簇的探索及五个显著潜在表位的鉴定
Virusdisease. 2021 Dec;32(4):774-783. doi: 10.1007/s13337-021-00737-9. Epub 2021 Sep 7.
7
Evolutionary warning system for COVID-19 severity: Colony predation algorithm enhanced extreme learning machine.COVID-19 严重程度的进化预警系统:集群捕食算法增强型极限学习机。
Comput Biol Med. 2021 Sep;136:104698. doi: 10.1016/j.compbiomed.2021.104698. Epub 2021 Jul 30.
8
Concordance of Chest CT and Nucleic Acid Testing in Diagnosing Coronavirus Disease Outside its District of Origin (Wuhan, China).胸部 CT 与核酸检测在诊断起源地(中国武汉)以外地区的新型冠状病毒病中的一致性。
Clinics (Sao Paulo). 2020;75:e1910. doi: 10.6061/clinics/2020/e1910. Epub 2020 Aug 19.
9
Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.了解针对新型冠状病毒(COVID-19)的免疫反应和治疗挑战。
Life Sci. 2020 Sep 15;257:118058. doi: 10.1016/j.lfs.2020.118058. Epub 2020 Jul 9.
10
Coronavirus Disease 2019-COVID-19.新型冠状病毒肺炎。
Clin Microbiol Rev. 2020 Jun 24;33(4). doi: 10.1128/CMR.00028-20. Print 2020 Sep 16.